Want to join the conversation?
Materials engineering solutions company $AMAT said its combined edge and CVD revenues for 2Q16 are at a nine year high. In China, the company is well positioned with record quarterly semiconductor orders. In foundry, $AMAT expects investment levels for FY16 to be similar to 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.